{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:35:45Z","timestamp":1790742945012,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 136778"],"award-info":[{"award-number":["MOP 136778"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.parkreldis.2015.08.003","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T08:04:27Z","timestamp":1439366667000},"page":"S101-S105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S1","title":["Molecular imaging and neural networks in impulse control disorders in Parkinson's disease"],"prefix":"10.1016","volume":"22","author":[{"given":"I.","family":"Aracil-Bola\u00f1os","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2015.08.003_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.parkreldis.2011.01.009","article-title":"Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies","volume":"17","author":"Hassan","year":"2011","journal-title":"Park Relat. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-011-2550-7","article-title":"Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity","volume":"219","author":"Leeman","year":"2012","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib4","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case-control study","volume":"69","author":"Voon","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.21454","article-title":"Dopamine and impulse control disorders in Parkinson's disease","volume":"64","author":"Weintraub","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib6","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1471-4159.1981.tb10843.x","article-title":"Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease","volume":"36","author":"Javoy-Agid","year":"1981","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","article-title":"Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders","volume":"8","author":"Voon","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","article-title":"Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series","volume":"22","author":"Gallagher","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.wnl.0000252368.25106.b6","article-title":"Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists","volume":"68","author":"Tippmann-Peikert","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/WNF.0b013e3182281b2f","article-title":"Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas","volume":"34","author":"Martinkova","year":"2011","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00429-011-0314-0","article-title":"Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding","volume":"216","author":"Cilia","year":"2011","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11910-013-0386-8","article-title":"The functional anatomy of impulse control disorders","volume":"13","author":"Probst","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib13","first-page":"659","article-title":"Imaging impulse control disorders in Parkinson's disease and their relationship to addiction","volume":"120","author":"Ray","year":"2013"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib14","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.neuroimage.2008.06.002","article-title":"Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors","volume":"42","author":"Volkow","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib15","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","article-title":"Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study","volume":"132","author":"Steeves","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours","volume":"134","author":"O'Sullivan","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib17","first-page":"1504","article-title":"Single versus multiple impulse control disorders in Parkinson's disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release","author":"Wu","year":"2015","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib18","article-title":"Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole","volume":"17","author":"Lemke","year":"2005"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/brain\/awn337","article-title":"Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-nave Parkinson's disease","volume":"132","author":"Boileau","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/add.12066","article-title":"The D2\/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride","volume":"108","author":"Boileau","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mds.26135","article-title":"[11C]-(+)-PHNO PET imaging of dopamine D2\/3 receptors in Parkinson's disease with impulse control disorders","volume":"30","author":"Payer","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)60041-6","article-title":"Imaging insights into basal ganglia function, Parkinson's disease, and dystonia","author":"Stoessl","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib23","first-page":"134","article-title":"Eating disorders with binge-eating behaviour are associated with the s allele of the 3\u2032-UTR VNTR polymorphism of the dopamine transporter gene","volume":"29","author":"Shinohara","year":"2004","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","article-title":"Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling","volume":"39","author":"Cilia","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib25","first-page":"1","article-title":"Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease","volume":"00","author":"Vriend","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.1185778","article-title":"Dopaminergic network differences in human impulsivity","volume":"329","author":"Buckholtz","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","article-title":"Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study","volume":"48","author":"Ray","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib28","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/cercor\/bhr354","article-title":"Orbitofrontal connectivity with resting-state networks is associated with midbrain dopamine D3 receptor availability","volume":"22","author":"Cole","year":"2012","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib29","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1038\/npp.2009.124","article-title":"Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?","volume":"34","author":"Van Eimeren","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib30","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181fc27fa","article-title":"Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD","volume":"75","author":"Van Eimeren","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib31","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/hbm.22344","article-title":"Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions","volume":"35","author":"Antonelli","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mds.26068","article-title":"Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease","volume":"30","author":"Napier","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.003_bib33","first-page":"1","article-title":"Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate","author":"Beaudoin-Gobert","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.08.003_bib34","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2967\/jnumed.108.050849","article-title":"Opioid receptor PET reveals the psychobiologic correlates of reward processing","volume":"49","author":"Schreckenberger","year":"2008","journal-title":"J.\u00a0Nucl. Med."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015003351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015003351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T04:20:53Z","timestamp":1537417253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802015003351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":34,"alternative-id":["S1353802015003351"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.003","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular imaging and neural networks in impulse control disorders in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}